ATYR vs LYFT · rev $190.0K vs P/E 108, rev $3.49B
aTyr Pharma, Inc. (ATYR) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported LYFT revenue for 2026-06-30 was $3.49B. Net income was $64.5M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
ATYR currently screens at market cap $471.7M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the ATYR and LYFT stock pages for the full models.
Not investment advice.